Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer

被引：2
|
作者：
Miaris, Nikolaos [1 ]
Sgouros, Joseph [1 ]
Gerolympou, Margarita [1 ]
Spyropoulos, Basilios [2 ]
Drakopoulos, Dionysios [3 ]
Gkoura, Stefania [1 ]
Res, Helen [1 ]
Samantas, Epaminondas [1 ]
机构：
[1] Agioi Anargyroi Gen Oncol Hosp Kifisia, Dept Med Oncol 3, Noufaron & Timiou Stavrou 14, Athens 14564, Greece
[2] 401 Gen Mil Hosp Athens, Dept Internal Med 1, Athens, Greece
[3] 401 Gen Mil Hosp Athens, Dept Radiol, Athens, Greece
来源：
JOURNAL OF GASTROINTESTINAL CANCER | 2019年 / 50卷 / 01期
关键词：
LEUKOENCEPHALOPATHY SYNDROME; OXALIPLATIN;
D O I：
10.1007/s12029-017-9986-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：123 / 126
页数：4
相关论文
共 50 条
  • [1] Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer
    Nikolaos Miaris
    Joseph Sgouros
    Margarita Gerolympou
    Basilios Spyropoulos
    Dionysios Drakopoulos
    Stefania Gkoura
    Helen Res
    Epaminondas Samantas
    Journal of Gastrointestinal Cancer, 2019, 50 : 123 - 126
  • [2] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [3] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [4] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [5] Safety and efficacy of aflibercept in combination with fluorouracil, leucovorin and irinotecan in the treatment of Asian patients with metastatic colorectal cancer
    Chong, Dawn Q.
    Manalo, Mary
    Imperial, Marlowe
    Teo, Patrick
    Yong, Grace
    Ng, Matthew
    Tan, Iain B. H.
    Choo, Su Pin
    Chua, Clarinda
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (03) : 275 - 283
  • [6] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [7] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [8] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
  • [9] A Phase II study of ANGIOZYME® in combination with 5-fluorouracil, leucovorin and irinotecan in the treatment of metastatic colorectal cancer patients
    Usman, N
    Venook, A
    Hurwitz, H
    Cunningham, C
    Fuchs, C
    Burris, H
    Schwartzberg, L
    Pelley, R
    Miller, WH
    Modiano, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S72 - S72
  • [10] Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
    Meyerhardt, Jeffrey A.
    Clark, Jeffrey W.
    Supko, Jeffrey G.
    Eder, Joseph P.
    Ogino, Shuji
    Stewart, Clinton F.
    D'Amato, Ferdinando
    Dancey, Janet
    Enzinger, Peter C.
    Zhu, Andrew X.
    Ryan, David P.
    Earle, Craig C.
    Mayer, Robert J.
    Michelini, Ann
    Kinsella, Kate
    Fuchs, Charles S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 661 - 670
12345